MaximilianBaur

European Counsel

München + 49.89.20.60.42.220

Maximilian Baur ist Fachanwalt für Arbeitsrecht. Seine Tätigkeit umfasst die Prozessführung in arbeitsgerichtlichen Verfahren, sowie die Beratung von Unternehmen bei Verhandlungen mit Betriebsräten und Gewerkschaften. Herr Baur verfügt über umfangreiche Erfahrung im Verfahren der betrieblichen Einigungsstelle. Er berät laufend bei der Gestaltung von Anstellungs- und Aufhebungsverträgen sowie bei allen arbeitsrechtlichen Fragen im Zusammenhang mit Transaktionen und Restrukturierungen. Ein weiterer Schwerpunkt seiner Tätigkeit sind Integrationsprojekte, wie z.B. die Einführung neuer Vergütungssysteme oder die Implementierung globaler Unternehmensrichtlinien.

Herr Baur verfügt über vertiefte Praxiserfahrung im Bereich der internationalen Personalarbeit, insbesondere zur Entsendung von Mitarbeitern, zu europaweiten Bonusmodellen und zu grenzüberschreitenden Reorganisationen. Darüber hinaus ist er auf Fragen des Datenschutzes am Arbeitsplatz spezialisiert, wie z.B. Betriebsvereinbarungen über den Einsatz von IT-Systemen.

Erfahrung

  • Cardinal Health to sell its Cordis business to Hellman & Friedman for approximately $1 billionJones Day is advising Cardinal Health on the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • Solvay sold barium, strontium and sodium percarbonate businesses to Latour CapitalJones Day advised Solvay S.A., a publicly listed chemical company based in Brussels, Belgium, on the combined sale of its technical-grade barium and strontium business in Germany, Spain and Mexico, and its sodium percarbonate business in Germany to Latour Capital.
  • Wellington Partners, MIG GmbH & Co. Fonds 16, and Salvia GmbH invest €15 million in growth financing of Creative BalloonsJones Day represented Wellington Partners Life Sciences V, a leading European Venture Capital firm investing in early- and growth-stage Life Science companies, together with MIG GmbH & Co. Fonds 16 and Salvia GmbH, in connection with their €15 million growth investment in Creative Balloons GmbH, a specialist in researching and developing ultra-thin polyurethane (PUR) balloons for medical device applications, namely catheter manufacturing.
  • Astellas returns rights to Eligard® in Europe, Middle East, CIS, and Asia to TolmarJones Day represented Astellas Pharma Europe Ltd. in connection with a series of transactions, including the sale of related assets, in which Astellas returned its in-licensing rights to Eligard® (leuprorelin acetate for injectable suspension), a treatment for advanced prostate cancer, sold by Astellas in Europe, the Middle East, the Commonwealth of Independent States (CIS) and Asia, to Tolmar International Limited.
  • STERIS to acquire Cantel Medical for $3.6 billionJones Day is advising STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • Astellas transfers DIFICLIR in Europe, Middle East, Africa, and selected CIS to Swiss Tillotts Pharma AG for €109 millionJones Day advised Astellas Pharma Europe Ltd. on the sale of distribution rights to the product "DIFICLIR" in Europe, Middle East, Africa, and selected Commonwealth of Independent States (CIS) countries to Swiss Tillotts Pharma AG for €109 million.
  • Materion acquires Optics Balzers, AG for $160 millionJones Day advised Materion Corporation, a global supplier of highly engineered advanced enabling materials, in its $160 million acquisition of Optics Balzers, AG, an industry leader in thin film optical coatings.
  • PolyOne acquires Clariant color and additive masterbatch business for $1.5 billionJones Day advised PolyOne Corporation in the $1.5 billion purchase of Clariant’s global color and additive masterbatch business.
  • ebase GmbH to acquire securities business of Augsburger AktienbankJones Day is advising European Bank of Financial Services GmbH (ebase) in the acquisition of the securities business of Augsburger Aktienbank AG.
  • Edge Case Research acquires TerraLoupe TechnologyJones Day advised Edge Case Research, Inc. in its acquisition of assets of TerraLoupe GmbH.
  • Rising Point Capital acquires Conco HoldingsJones Day advised Rising Point Capital, LLC in its acquisition of Conco Holdings, a provider of low-pressure, mechanical heat exchanger tube cleaning and non-destructive testing services.
  • Amadeus FiRe AG acquires COMCAVE Holding GmbH, Dortmund for €200 millionJones Day advised Amadeus FiRe AG, Frankfurt, on the €200 million acquisition of 100% of the shares in the retraining specialist COMCAVE Holding GmbH, Dortmund.
  • Western Digital sells IntelliFlash™ business to DataDirect Networks, Inc. (DDN®)Jones Day advised Western Digital Corp. in the sale of its IntelliFlash™ business to DataDirect Networks, Inc. (DDN®), a global leader in artificial intelligence (AI) and multi-cloud data management.
  • HOERBIGER Group acquires Deublin CompanyJones Day advised HOERBIGER Group, a privately-held industrial company headquartered in Switzerland, on the acquisition of Deublin Company, the leading manufacturer of rotating unions in the world.
  • Nordson acquires Optical Control GmbH & Co. KGJones Day advised Nordson Corporation in its acquisition of Optical Control GmbH & Co. KG, a German designer and developer of high speed, fully automatic counting systems utilizing x-ray technology.
  • *We use cookie to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.